Ampersand Biomedicines’ map of all tissue in the human body reveals “addresses,” identifying markers on disease targets that are not found on healthy tissue. The company aims to improve the targeting of biologic drugs in order to reduce on-target, off-tissue toxicity. The post Flagship’s Ampersand Bio Adds $65M to Solve One of the Top Challenges…
Study finds reductions in suicidal ideation, depression and anxiety among patients in collaborative care setting
By reducing the time spent on administrative tasks, AI scribes allow physicians to focus more on what truly matters — patient care. As the technology continues to evolve and improve, its adoption will likely become more widespread, further enhancing its benefits. The post Evidence-Based Medicine: AI Scribes Actually Work appeared first on MedCity News.
Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players. The post With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and…
AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions. The post AI Can Accelerate Discovery — Development Still Decides What Advances appeared first on MedCity News.
UCSF’s Lisa Rotenstein, M.D., M.B.A., discusses a Health Affairs Commentary article about the relationship between physicians, advanced practice providers in primary care
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that recently occurred in the healthcare world. She also interviewed Amy Abernethy, who recently co-founded Highlander Health with fellow healthcare veteran Brad Hirsch. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Amy Abernethy, Co-Founder…
GSK drug Nucala has expanded its FDA-approved uses to include maintenance treatment of chronic obstructive pulmonary disease that’s driven by eosinophils, a type of immune cell. The antibody drug will compete against the blockbuster Sanofi product Dupixent, which expanded its FDA approval to COPD last year. The post GSK Inflammation Drug Lands New FDA Nod…
Decenas de expertos en VIH de los Centros para el Control y Prevención de Enfermedades (CDC) recibieron correos electrónicos el miércoles 11 de junio revocando las notificaciones de despido recibidas diez semanas atrás. Sin embargo, el daño a sus proyectos podría ser permanente, y las restricciones continuas a sus investigaciones perjudicarán vidas, dijeron científicos de…